Fractyl Health, Inc. Selling, General and Administrative Expense
Fractyl Health, Inc. (GUTS) reported Selling, General and Administrative Expense of $5.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-10
- Fractyl Health, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $5.28M, a 7.22% increase year-over-year.
- Fractyl Health, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $5.22M, a 1.92% decline year-over-year.
- Fractyl Health, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $6.79M, a 37.69% increase year-over-year.
- Fractyl Health, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $5.24M, a 9.17% increase year-over-year.
- Fractyl Health, Inc. selling, general and administrative expense for fiscal 2025 was $22.28M, a 3.56% decline from fiscal 2024.
- Fractyl Health, Inc. selling, general and administrative expense for fiscal 2024 was $23.10M, a 79.92% increase from fiscal 2023.
- Fractyl Health, Inc. selling, general and administrative expense for fiscal 2023 was $12.84M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.28M 10-Q · filed 2026-08-10 | $10.51M 10-Q · filed 2026-08-10 | $17.30M derived: sum of 3 quarters · filed 2026-08-10 | $22.53M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $5.22M 10-Q · filed 2026-05-12 | $12.01M derived: sum of 2 quarters · filed 2026-05-12 | $17.25M derived: sum of 3 quarters · filed 2026-05-12 | $22.18M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $12.03M derived: sum of 2 quarters · filed 2026-03-24 | $16.96M derived: sum of 3 quarters · filed 2026-08-10 | $22.28M 10-K · filed 2026-03-24 |
| 2025-09-30 | $5.24M 10-Q · filed 2025-11-12 | $10.16M derived: sum of 2 quarters · filed 2026-08-10 | $15.49M 10-Q · filed 2025-11-12 | $20.42M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $4.93M 10-Q · filed 2026-08-10 | $10.25M 10-Q · filed 2026-08-10 | $15.18M derived: sum of 3 quarters · filed 2026-08-10 | $19.98M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $5.32M 10-Q · filed 2026-05-12 | $10.26M derived: sum of 2 quarters · filed 2026-05-12 | $15.05M derived: sum of 3 quarters · filed 2026-05-12 | $21.30M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $9.73M derived: sum of 2 quarters · filed 2026-03-24 | $15.97M derived: sum of 3 quarters · filed 2026-03-24 | $23.10M 10-K · filed 2026-03-24 |
| 2024-09-30 | $4.80M 10-Q · filed 2025-11-12 | $11.04M derived: sum of 2 quarters · filed 2025-11-12 | $18.17M 10-Q · filed 2025-11-12 | $20.99M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $6.24M 10-Q · filed 2025-08-12 | $13.37M 10-Q · filed 2025-08-12 | $16.19M derived: sum of 3 quarters · filed 2025-08-12 | $20.70M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $7.13M 10-Q · filed 2025-05-13 | $9.95M derived: sum of 2 quarters · filed 2025-05-13 | $14.45M derived: sum of 3 quarters · filed 2025-05-13 | $17.21M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $7.32M derived: sum of 2 quarters · filed 2025-03-03 | $10.08M derived: sum of 3 quarters · filed 2025-03-03 | $12.84M 10-K · filed 2025-03-03 |
| 2023-09-30 | $4.50M 10-Q · filed 2024-11-12 | $7.26M derived: sum of 2 quarters · filed 2024-11-12 | $10.02M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $2.76M 10-Q · filed 2024-08-14 | $5.52M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $2.76M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |